Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lankester, Arjan C  [Clear All Filters]
2023
de Bruin LMOtt, Lankester AC, Staal FJT. Advances in gene therapy for inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2023.
von Asmuth EGJ, Putter H, Mohseny AB, Schilham MW, Snowden JA, Saccardi R, Lankester AC. Automating outcome analysis after stem cell transplantation: The YORT tool. Bone Marrow Transplant. 2023.
Cseh A, Galimard J-E, De La Fuente J, Isgrò A, Zecca M, Garwer B, Biffi A, Aljurf M, Sundin M, Belendez C, et al. Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties. Br J Haematol. 2023.
van der Stoep MYEileen C, Bense JE, de Kloet LC, von Asmuth EGJ, de Pagter APJ, Hannema SE, Guchelaar H-J, Zwaveling J, Lankester AC. Effect of busulfan and treosulfan on gonadal function after allogeneic stem cell transplantation in children and adolescents with nonmalignant diseases is not exposure-dependent. Transplant Cell Ther. 2023.
Kaiser FMarc Phili, Janowska I, Menafra R, de Gier M, Korzhenevich J, Pico-Knijnenburg I, Khatri I, Schulz AS, Kuijpers TW, Lankester AC, et al. IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion. Blood. 2023.
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, von Bismarck P, Bloomfield MPhDMarké, Booth C, Buddingh EP, et al. JAK-inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID and EBMT IEWP retrospective study. J Allergy Clin Immunol. 2023.
Bense JE, Stiggelbout AM, Lankester AC, de Pagter APJ. Long-term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseases. Pediatr Blood Cancer. 2023:e30638.
von Asmuth EGj, Neven B, Albert MH, Mohseny AB, Schilham MW, Binder H, Putter H, Lankester AC. Predicting patient death after allogeneic SCT for inborn errors using machine learning (PREPAD): An EBMT IEWP study. Transplant Cell Ther. 2023.
Bense JE, Guilonard N, Zwaginga F, Stiggelbout AM, Louwerens M, Mekelenkamp H, Lankester AC, Pieterse AH, de Pagter APJ. The value of using patient-reported outcomes for health screening during long-term follow-up after paediatric stem cell transplantation for nonmalignant diseases. Health Expect. 2023.
2022
Achini-Gutzwiller FR, van der Zijde CMJol-, Jansen-Hoogendijk AM, Lankester AC, Bredius RGM, van Tol MJD, Moes DJan AR, Schilham MW. Development and Validation of an Efficient and Highly Sensitive ELISA for Alemtuzumab Quantification in Human Serum and Plasma. Ther Drug Monit. 2022.
Bense JE, Welle LTer, Mekelenkamp H, Schimmel M, Louwerens M, Lankester AC, Pieterse AH, de Pagter APJ. Exploring the long-term psychosocial impact of paediatric haematopoietic stem cell transplantation for nonmalignant diseases. Health Expect. 2022.
Albert MH, Sirait T, Eikema D-J, Bakunina K, Wehr C, Suarez F, Fox MLaura, Mahlaoui N, Gennery AR, Lankester AC, et al. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity, an EBMT IEWP study. Blood. 2022.
Albert MH, Slatter MA, Gennery AR, Güngör T, Bakunina K, Markovitch B, Hazelaar S, Sirait T, Courteille V, Aiuti A, et al. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis. Blood. 2022.
Schuetz C, Gerke J, Ege MJohannes, Walter JEszter, Kusters M, Worth AJJ, Kanakry JA, Dimitrova D, Wolska-Kusnierz B, Chen K, et al. Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT. Blood. 2022.
van Halteren AGS, Suwandi J, Tuit S, Borst J, Laban S, Tsonaka R, Struijk A, Wiekmeijer A-S, van Pel M, Roep BO, et al. A UNIQUE IMMUNE SIGNATURE IN BLOOD SEPARATES THERAPY-REFRACTORY FROM THERAPY-RESPONSIVE ACUTE GRAFT-VERSUS-HOST DISEASE. Blood. 2022.
2021
Lugthart G, Jordans CCE, de Pagter APJ, Bresters D, van der Zijde CMJol-, Bense JE, van Rooij-Kouwenhoven RWG, Sukhai RN, Louwerens M, Dorresteijn EM, et al. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation. Kidney Int. 2021.
Verhoeven D, Schonenberg-Meinema D, Ebstein F, Papendorf JJ, Baars PA, van Leeuwen EMM, Jansen MH, Lankester AC, van der Burg M, Florquin S, et al. Hematopoietic stem cell transplantation in a patient with proteasome-associated auto-inflammatory syndrome (PRAAS). J Allergy Clin Immunol. 2021.
van der Stoep MYEileen C, Bertaina A, Moes DJan AR, Algeri M, Bredius RGM, Smiers FJW, Berghuis D, Buddingh EP, Mohseny AB, Guchelaar H-J, et al. Impact of treosulfan exposure on early and long-term clinical outcome in pediatric allogeneic HSCT recipients: a prospective multicenter study. Transplant Cell Ther. 2021.
Dimitrova D, Nademi Z, Maccari MElena, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, et al. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J Allergy Clin Immunol. 2021.
Yang L, Booth C, Speckmann C, Seidel MG, Worth AJj, Kindle G, Lankester AC, B G, Gennery AR, Seppänen MRj, et al. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency. J Allergy Clin Immunol. 2021.
2020
Felber M, Steward CG, Kentouche K, Fasth A, Wynn RF, Zeilhofer U, Haunerdinger V, Volkmer B, Prader S, Gruhn B, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998-2010.
2019
Bekker V, Zwittink RD, Knetsch CW, Sanders IMJG, Berghuis D, Heidt PJ, Vossen JMJJ, de Vos WM, Belzer C, Bredius RGM, et al. Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment During Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019.
Ferrua F, Galimberti S, Courteille V, Slatter MAnne, Booth C, Moshous D, Neven B, Blanche S, Laberko A, Shcherbina A, et al. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study. J Allergy Clin Immunol. 2019.
G Visser L, Tollenaar LSA, Bekker V, Pas ABTe, Lankester AC, Oepkes D, Lopriore E, Verbeek L. Leukocyte Counts and Other Hematological Values in Twin-Twin Transfusion Syndrome and Twin Anemia-Polycythemia Sequence. Fetal Diagn Ther. 2019:1-6.
2015
Admiraal R, van Kesteren C, van der Zijde CMJol-, Lankester AC, Bierings MB, Egberts TCG, van Tol MJD, Knibbe CAJ, Bredius RGM, Boelens JJ. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2015;2(5):e194-203.

Pages